Purity >99% HPLC
RUO — Research use only
Not for human or veterinary use.
GLOW 70mg
Research Peptide (Blend) · 70mg Lyophilised Powder
£59.99
Pay by Bank · Powered by Fena
FCA-regulated open banking — authenticated in your banking app, no card details shared.
For research purposes only. Not for human or veterinary use. All products must be handled by qualified researchers in appropriate laboratory conditions.
Purity You Can Verify
Every batch undergoes High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) analysis before release. Independent third-party testing confirms purity exceeds 99% for each batch — not as a target, but as a minimum standard. The batch-specific Certificate of Analysis is published on our COA page, where you can match your vial's batch number to its results.
Batch COA available on request
View COA library →Manufactured with Pharmaceutical-Grade Process Controls
Our UK facility operates under cGMP (current Good Manufacturing Practice) guidelines, applying pharmaceutical-grade process controls to research peptide production. Synthesis, purification, lyophilisation, and final packaging all follow documented SOPs with full batch traceability from raw material to dispatch.
Batch-Specific Documentation
Every vial is labelled with a unique batch number tied to its specific production batch. Match it to the Certificate of Analysis on our COA page for HPLC purity data, MS identity confirmation, and production date — giving researchers full traceability and reproducibility assurance for every experiment.
Batch COA available on request
View COA library →Stored and Shipped Correctly
Lyophilised peptides are stored at -20°C from the moment of production. Orders are dispatched in temperature-appropriate packaging with discreet, plain outer packaging. Same-day dispatch on orders placed before 3 pm (UK working days).
>99%
Purity verified per batch
16+
Compounds in catalogue
100%
Batch-tested before dispatch
About GLOW 70mg
Research-context overview. Not medical advice. All products for research use only.
| Also known as | GHK-Cu + BPC-157 + TB-500 co-lyophilised research blend |
| CAS Number | 89030-95-5 |
| Molecular Formula | C₁₄H₂₂CuN₆O₄ |
| Molecular Weight | 401.9 g/mol (complex) |
| Purity | >99% HPLC (independently verified) |
| Status | Research Use Only (RUO) · Not for human or veterinary use |
GLOW 70mg | GHK-Cu · BPC-157 · TB-500 | Co-lyophilised Research Peptide Blend
Composition: GHK-Cu 50mg + BPC-157 10mg + TB-500 (Thymosin β-4) 10mg — 70mg total, co-lyophilised Purity: >99% HPLC per component Appearance: Light-blue lyophilised powder (copper content) Storage: –20°C (lyophilised); 2–8°C (reconstituted) Batch: G7392 — Exp. 05/2029
What Is GLOW?
GLOW is a co-lyophilised three-peptide research blend formulated for in-vitro studies of ECM remodelling, collagen gene expression, angiogenic signalling, and cytoskeletal dynamics. The blend combines GHK-Cu (copper tripeptide-1, 50mg) with BPC-157 (pentadecapeptide, 10mg) and TB-500 / Thymosin β-4 (43-aa actin-sequestering peptide, 10mg). Each component engages distinct molecular pathways, and the fixed-ratio blend is supplied at greater than 99% purity per component for reproducible experimental work.
Component Research Profiles
GHK-Cu (Copper Tripeptide-1; Gly-His-Lys·Cu²⁺) GHK-Cu is a copper(II)-complexed tripeptide (CAS 89030-95-5) first isolated from human plasma. Research has examined its effects on collagen and extracellular matrix gene expression: in fibroblast models, GHK-Cu has been investigated for its modulation of collagen I, collagen III, fibronectin, and decorin expression, alongside upregulation of matrix metalloproteinase (MMP) production and tissue inhibitors of metalloproteinases (TIMPs). Studies have also examined GHK-Cu in the context of angiogenic signalling via VEGF-A and its interactions with integrin-mediated wound contraction models. The characteristic blue appearance of GHK-Cu results from the Cu²⁺ coordination complex.
BPC-157 (Body Protection Compound-157) A 15-amino-acid pentadecapeptide studied in preclinical models for interactions with the nitric-oxide (NO) system and VEGFR2-associated angiogenic signalling. Research has also examined cytoprotective responses in GI mucosal tissue models and fibroblast activity in musculoskeletal contexts. See the standalone BPC-157 product for the full research profile.
TB-500 (Thymosin β-4; Tβ4) A 43-amino-acid N-acetylated actin-sequestering peptide studied for its role in G-actin/F-actin regulation, directional cell migration, and cytoskeletal dynamics in endothelial and stromal cell models. See the standalone TB-500 product for the full research profile.
Component Identifiers
| Property | GHK-Cu | BPC-157 | TB-500 (Tβ4) |
|---|---|---|---|
| CAS Number | 89030-95-5 | 137525-51-0 | 77591-33-4 |
| Molecular Formula | C₁₄H₂₂CuN₆O₄ | C₆₂H₉₈N₁₆O₂₂ | C₂₁₂H₃₅₀N₅₆O₇₈S |
| Molecular Weight | 401.9 g/mol (complex) | 1419.55 g/mol | 4963.44 g/mol |
| Blend Quantity | 50mg | 10mg | 10mg |
| Purity (each) | >99% HPLC | >99% HPLC | >99% HPLC |
Handling & Storage
Store the lyophilised GLOW blend at –20°C in the sealed vial until use. Reconstitute in sterile bacteriostatic water or an appropriate aqueous buffer immediately before use. Once reconstituted, aliquot and store at 2–8°C. Avoid repeated freeze-thaw cycles. The light-blue powder coloration is attributable to the copper(II) complex in GHK-Cu; this is expected and does not indicate degradation. All handling should comply with standard laboratory safety protocols and applicable institutional guidelines.
Certificate of Analysis
Every component is independently tested and supplied with a Certificate of Analysis confirming purity by HPLC. Batch G7392 — Exp. 05/2029. Available on request and via the Nexyra Lab COA verification portal.
Important Notice
This product is intended strictly for in vitro research and laboratory use only. GLOW blend is not approved for human or veterinary use by the FDA, EMA, or any other regulatory authority. It is not a drug, supplement, or food product. This product must not be administered to humans or animals. By purchasing this product, the buyer confirms they are a qualified researcher and will use the compound solely for lawful scientific research purposes.
Technical datasheet
Identity
| Molecular Formula | C₁₄H₂₂CuN₆O₄ |
| Molecular Weight | 401.9 g/mol (complex) |
| CAS Number | 89030-95-5 |
Compliance
| Intended use | Research use only — not for human or veterinary use |
| Documentation | Batch-specific Certificate of Analysis with every order |
| Country of manufacture | United Kingdom |
| Quality standard | >99% purity, HPLC-verified, cGMP-compliant |
What's Included
Research-grade vial
Lyophilised powder, sealed under inert gas
Certificate of Analysis
Batch-specific HPLC & MS verification
Tamper-evident seal
Intact seal confirms product integrity
Discreet packaging
Plain, unbranded outer packaging
COA & Testing
Every batch of GLOW 70mg is independently analysed by HPLC and Mass Spectrometry before dispatch. The Certificate of Analysis confirms purity, verifies molecular identity, and carries a unique batch number for full traceability.
Batch COA available on request
View COA library →Customer Reviews
No reviews yet
Be the first to review this product. Post-purchase review invitations are sent automatically.
How GLOW 70mg Compares
Compare key research properties side by side with similar compounds. Switch compounds in the dropdowns to explore the full catalogue.
Purity and storage specifications are consistent across all Nexyra Lab lyophilised compounds. Pharmacokinetic data (half-life etc.) is not shown as it requires owner-confirmed verified references. For research planning and laboratory use only.
Resources & Support
Documentation, tools, and assistance for your research.
Frequently Asked Questions
Is this product for research use only?
Yes. All Nexyra Lab products are strictly for in vitro research and laboratory use by qualified researchers. They are not approved for human or veterinary use by the FDA, EMA, or any other regulatory authority.
Is a Certificate of Analysis (COA) available?
Yes. A batch-specific COA from our independent third-party testing laboratory is published on our COA page — match your vial's batch number to access HPLC purity data, MS identity confirmation, batch number, and production date.
What does the Certificate of Analysis confirm?
The COA confirms: (1) purity ≥99% by HPLC; (2) molecular identity by mass spectrometry; (3) the batch number for traceability; and (4) the production date. It is produced by an independent laboratory, not by Nexyra Lab itself.
How should lyophilised peptides be stored?
Store lyophilised (freeze-dried) peptides at -20°C in a sealed, dry container away from light and moisture. Avoid repeated freeze-thaw cycles. Once reconstituted, store at 4°C and use within 30 days for most peptides.
How do I reconstitute lyophilised peptides?
For most peptides, use sterile bacteriostatic water (BAC water) or sterile saline. Add the solvent slowly down the inside of the vial — do not inject directly onto the powder. Gently swirl until dissolved; do not shake. Use our Reconstitution Calculator at /peptide-calculator to determine the exact volume for your target concentration.
What are your dispatch and delivery times?
Orders placed before 3 pm on UK working days are dispatched same day. Standard UK delivery typically arrives within 1–3 working days. All orders are shipped in discreet, plain outer packaging with no reference to the contents.
What is your returns policy?
Due to the nature of research compounds and cold-chain requirements, we are unable to accept returns on opened products. If a product arrives damaged or incorrect, please contact our team within 48 hours of receipt and we will resolve the issue promptly.
What purity standard do your peptides meet?
All Nexyra Lab peptides are independently verified at ≥99% purity by HPLC before dispatch. Mass Spectrometry confirms molecular identity. This applies to every batch — the COA is batch-specific, not a generic certificate.
